Journals / Üroonkoloji Bülteni / 2016 / Cilt: 15 - Sayı: 1

The Role of Radiology in Perivesical Invasion of Muscle-Invasive Bladder Cancer

Kas İnvaze Mesane Kanserinin Perivezikal İnvazyonunda Radyolojinin Rolü

Pages
22–25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In patients with confirmed MIBC, computed tomography (CT) or magnetic resonance imaging of abdomen and pelvis and the unenhanced CT of the chest is recommended for the optimal staging.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Bladder cancer is the most common cancer of the urinary tract.
📊
Key Findings & Data:At the initial diagnosis of bladder cancer, approximately 30% of the cases are diagnosed as muscle-invasive bladder cancer (MIBC).
💡
Conclusion & Impact:In patients with confirmed MIBC, computed tomography (CT) or magnetic resonance imaging of abdomen and pelvis and the unenhanced CT of the chest is recommended for the optimal staging.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Bladder cancer is the most common cancer of the urinary tract. At the initial diagnosis of bladder cancer, approximately 30% of the cases are diagnosed as muscle-invasive bladder cancer (MIBC). Metastases and depth of invasion are directly related to survival. In patients with MIBC, multimodal bladder-sparing treatments with chemotherapy and radiotherapy reveal comparable survival rates with radical cystectomy. Therefore, accurate and reliable staging of bladder cancer is of paramount importance in choosing the most appropriate treatment method. In patients with confirmed MIBC, computed tomography (CT) or magnetic resonance imaging of abdomen and pelvis and the unenhanced CT of the chest is recommended for the optimal staging. The aim of this review was to evaluate imaging of perivesical invasion in MIBC and their clinical usage.

Özet

Mesane kanseri üriner sistemin en sık görülen kanseridir. Mesane kanserlerinin yaklaşık %30'u tanıda kas invaze mesane kanseridir (KİMK) ve invazyon derinliği ile birlikte metastaz varlığı sağkalımla direkt ilişkilidir. KİMK hastalarında kemoterapi ve radyoterapi ile multimodal mesane koruyucu tedaviler, radikal sistektomi ile karşılaştırılabilir düzeyde sağkalım oranları ortaya koymaktadır. Bu nedenle doğru ve güvenilir evrelendirme, mesane kanserinde en uygun tedavinin seçiminde büyük önem taşımaktadır. KİMK'lerinin evrelendirmesinde abdominal ve pelvik bilgisayarlı tomografi (BT) veya manyetik rezonans görüntüleme ile birlikte kontrastsız toraks BT yapılmasını önerilmektedir. Bu derlemenin amacı KİMK'nin evrelemesinde perivezikal invazyonu göstermede görüntüleme yöntemlerini ve klinik kullanımlarını değerlendirmektir.

🔖

Cite This Article

ÖZ, İ. İ., MUNGAN, A. (2016). The Role of Radiology in Perivesical Invasion of Muscle-Invasive Bladder Cancer. Üroonkoloji Bülteni, Cilt: 15 - Sayı: 1, 22–25. https://ajindex.com/articles/334367

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Witjes JA, Comperat E, Cowan NC, et al. EAU guidelines on muscle- invasive and metastatic bladder cancer: Summary of the 2013 guidelines. Eur Urol 2014;65:778-792.
  2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
  3. Stenzl A, Cowan NC, De Santis M, et al. The Updated EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer. Eur Urol 2009;55:815-825.
  4. Gray PJ, Fedewa SA, Shipley WU, et al. Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: Results from the National Cancer Data Base. Eur Urol 2013;63:823-829.
  5. Mak RH, Hunt D, Shipley WU, et al. Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: A pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233. J Clin Oncol 2014;32:3801-3809.
  6. Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual: Springer New York; 2010.
  7. Cowan NC, Crew JP. Imaging bladder cancer. Curr Opin Urol 2010;20:409-413.
  8. Malayeri AA, Pattanayak P, Apolo AB. Imaging muscle-invasive and metastatic urothelial carcinoma. Curr Opin Urol 2015;25:441-448.
  9. Voges GE, Tauschke E, Stockle M, et al. Computerized tomography: An unreliable method for accurate staging of bladder tumors in patients who are candidates for radical cystectomy. J Urol 1989;142:972-974.
  10. Kim JK, Park SY, Ahn HJ, et al. Bladder cancer: Analysis of multi- detector row helical CT enhancement pattern and accuracy in tumor detection and perivesical staging. Radiology 2004;231:725-731.
  11. Verma S, Rajesh A, Prasad SR, et al. Urinary bladder cancer: Role of MR imaging. Radiographics 2012;32:371-387.
  12. Tekes A, Kamel I, Imam K, et al. Dynamic MRI of bladder cancer: Evaluation of staging accuracy. AJR Am J Roentgenol 2005;184:121-127. de Haas RJ, Steyvers MJ, Fütterer JJ. Multiparametric MRI of the bladder: Ready for clinical routine? AJR Am J Roentgenol 2014;202:1187-1195.
  13. Kantarcı F, Olgun DÇ, Dikici AS. Mesane kanserlerinde tanıyı kolaylaştırıcı radyolojik yöntemler. Üroonkoloji Bülteni 2013;12:54-57.
  14. Daneshmand S, Ahmadi H, Huynh LN, et al. Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: Results from a prospective study. Urology 2012;80:1313-1318.
  15. Kim B, Semelka RC, Ascher SM, et al. Bladder tumor staging: Comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and l